Lipworth Wendy, Axler Renata
University of Sydney, Sydney, Australia.
University of Toronto, Toronto, Canada.
J Med Ethics. 2016 Jul;42(7):445-9. doi: 10.1136/medethics-2015-103048. Epub 2016 Mar 25.
In recent years, it has become almost axiomatic that biomedical research and clinical practice should be 'innovative'-that is, that they should be always evolving and directed towards the production, translation and implementation of new technologies and practices. While this drive towards innovation in biomedicine might be beneficial, it also raises serious moral, legal, economic and sociopolitical questions that require further scrutiny. In this article, we argue that biomedical innovation needs to be accompanied by a dedicated 'bioethics of innovation' that attends systematically to the goals, process and outcomes of biomedical innovation as objects of critical inquiry. Using the example of personalised or precision medicine, we then suggest a preliminary framework for a bioethics of innovation, based on the research policy initiative of 'Responsible Innovation'. We invite and encourage critiques of this framework and hope that this will provoke a challenging and enriching new bioethical discourse.
近年来,生物医学研究和临床实践应具有“创新性”几乎已成为一条公理,也就是说,它们应不断发展,并致力于新技术和实践的产生、转化与应用。虽然这种对生物医学创新的推动可能有益,但它也引发了一些严重的道德、法律、经济和社会政治问题,需要进一步审视。在本文中,我们认为生物医学创新需要有专门的“创新生物伦理学”相伴,该学科要系统地将生物医学创新的目标、过程和结果作为批判性探究的对象。然后,我们以个性化或精准医学为例,基于“负责任创新”的研究政策倡议,提出了一个创新生物伦理学的初步框架。我们欢迎并鼓励对这一框架的批评,希望这将引发一场具有挑战性且丰富充实的新生物伦理讨论。